Informations générales (source: ClinicalTrials.gov)

NCT03877575 En recrutement
Lyon Uveitis Study (LYS)
Observational
  • Uvéite
Hospices Civils de Lyon (Voir sur ClinicalTrials)
janvier 2016
janvier 2025
29 juin 2024
Uveitis or inflammation of the uveal tract results from a heterogeneous collection of disorders of varying etiologies and pathogenic mechanisms. Uveitis is relatively frequent in industrial countries with an estimation of 115 cases for 100 000 persons and is associated with a blindness risk of 10%. Causes of uveitis can be related to different etiologies (infectious, inflammatory or general inflammatory diseases). Therapeutic care is based on ophthalmologic and systemic diagnosis and treatment strategy depends on the severity of inflammation. The main objective of the Lyon uveitis study is to analyze the uveitis ophthalmologic etiology and diagnostic and therapeutic care of the patients. This study is proposed to all patients diagnosed for uveitis and referred to the Department of Internal Medicine of the Croix Rousse hospital, Lyon, france for etiologic diagnosis or treatment. Analysis of i) patients' characteristics, ii) the relevance of complementary exams to determine the uveitis etiology, iii) treatment used. This study will allow a better characterization of the disease on diagnosis practices and therapeutic care.

Etablissements

Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
Department of Internal Medicine, Croix-Rousse Hospital, Hospices Civils de Lyon - 69004 - Lyon - France Pascal Sève, MD, PhD En recrutement Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Diagnosis of uveitis

- First consultation in the Department of Internal Medicine at the Croix-Rousse
hospital, Lyon, France



-